CN Patent

CN102470130A — 联苯化合物的结晶游离碱形式

Assigned to Theravance Biopharma R&D IP LLC · Expires 2012-05-23 · 14y expired

What this patent protects

本发明提供联苯-2-基氨基甲酸1-(2-{[4-(4-氨甲酰基哌啶-1-基甲基)苯甲酰基]甲基氨基}乙基)哌啶-4-基酯的两种结晶游离碱形式。本发明还提供包含所述结晶游离碱或使用所述结晶游离碱制备的医药组合物；用于制备所述结晶游离碱的方法和中间体；和使用所述结晶游离碱治疗肺病症的方法。

USPTO Abstract

本发明提供联苯-2-基氨基甲酸1-(2-{[4-(4-氨甲酰基哌啶-1-基甲基)苯甲酰基]甲基氨基}乙基)哌啶-4-基酯的两种结晶游离碱形式。本发明还提供包含所述结晶游离碱或使用所述结晶游离碱制备的医药组合物；用于制备所述结晶游离碱的方法和中间体；和使用所述结晶游离碱治疗肺病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102470130A
Jurisdiction
CN
Classification
—
Expires
2012-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Theravance Biopharma R&D IP LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.